Earnings Conference Call to be Held on November 13, 2008 at 8:00 am
(Eastern) / 5:00 am (Pacific) / 9:00 pm (Beijing/Hong Kong)
SHANGHAI, China, Oct. 23 /Xinhua-PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release unaudited financial results for the third quarter 2008 after the US market close on Wednesday, November 12, 2008.
The earnings release will be available on the investor relations section of its website at http://www.wuxiapptec.com .
Following the earnings announcement, WuXi PharmaTech senior management
will host a conference call at 8:00 am (Eastern) / 5:00 am (Pacific) / 9:00
pm (Beijing/Hong Kong) on Thursday, November 13, 2008 to discuss its 2008
third quarter financial results and recent business activities. The
conference call may be accessed by calling:
Conference ID: 70474888
United States 866-586-2813
China, Northern Region 10-800-611-0127
China, Southern Region 10-800-361-0079
Hong Kong 800-965-808
United Kingdom 0-800-056-9662
A telephone replay will be available two hours after the call's completion until December 14, 2008 at (US) +1-866-214-5335/ (HK) 800-901-596 / (China) 10-800-140-0386 / (UK) 0-800-731-7846 / (International) +61-2-8235-5000. Passcode: 70474888.
A live webcast of the conference call and replay will be available in the investor relations section of WuXi PharmaTech's website at http://www.wuxiapptec.com .
About WuXi PharmaTech
WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical
device R&D outsourcing company, with operations in China and the United
States. As a research-driven and customer-focused company, WuXi PharmaTech
provides pharmaceutical, biotechnology and medical device companies a broad
and integrated portfolio of laboratory and manufacturing services
throughout the drug and medical device R&D process. WuXi PharmaTech's
services are designed to assist its global partners in shortening the cycle
and lowering the cost of drug and medical device R&D. The operating
subsidiaries of WuXi PharmaTech are known as WuXi AppTec. For more
information, please visit: http://www.wuxiapptec.com .
For further information, please contact:
WuXi PharmaTech (Cayman) Inc.
Dr. Hai Mi
Executive Director of Investor Relations and Business Planning
Vice President of Investor Relations
|SOURCE WuXi PharmaTech (Cayman) Inc.|
Copyright©2008 PR Newswire.
All rights reserved